4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001746473-26-000054
Options or other derivatives
- Chief Financial Officer acquired 592,495 shares (grant or award)
- Chief Financial Officer returned 592,495 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cummings Keith Lamont Chief Financial Officer | 2026-04-17 | Returned to the company · Stock Option (Right to Buy) | −76,047 | 0 | D: show line 1 in the form | ||
| Cummings Keith Lamont Chief Financial Officer | 2026-04-17 | Grant or award · Stock Option (Right to Buy) | +76,047 | 76,047 | D: show line 2 in the form | ||
| Cummings Keith Lamont Chief Financial Officer | 2026-04-17 | Returned to the company · Stock Option (Right to Buy) | −18,198 | 0 | D: show line 3 in the form | ||
| Cummings Keith Lamont Chief Financial Officer | 2026-04-17 | Grant or award · Stock Option (Right to Buy) | +18,198 | 18,198 | D: show line 4 in the form | ||
| Cummings Keith Lamont Chief Financial Officer | 2026-04-17 | Returned to the company · Stock Option (Right to Buy) | −74,250 | 0 | D: show line 5 in the form | ||
| Cummings Keith Lamont Chief Financial Officer | 2026-04-17 | Grant or award · Stock Option (Right to Buy) | +74,250 | 74,250 | D: show line 6 in the form | ||
| Cummings Keith Lamont Chief Financial Officer | 2026-04-17 | Returned to the company · Stock Option (Right to Buy) | −124,000 | 0 | D: show line 7 in the form | ||
| Cummings Keith Lamont Chief Financial Officer | 2026-04-17 | Grant or award · Stock Option (Right to Buy) | +124,000 | 124,000 | D: show line 8 in the form |
Loading xslF345X06/wk-form4_1776458561.xml…